Let's Say There's a Covid-19 Vaccine-Who Gets It First?
An immunization shot is still in development, but debate over who gets priority has already begun.
Send us a link
ELife Launches Service to Peer Review Preprints on BioRxiv
New initiative couples rapid release of new results with expert review.
Meet This Super-spotter of Duplicated Images in Science Papers
Elisabeth Bik quit her job to spot errors in research papers - and has become the public face of image sleuthing.
He Was a Science Star. Then He Promoted a Questionable Cure for Covid-19.
The man behind Trump's favorite unproven treatment has made a great career assailing orthodoxy. His claim of a 100 percent cure rate shocked scientists around the world.
Women's Research Plummets During Lockdown - but Articles from Men Increase
Many female academics say juggling their career with coronavirus childcare is overwhelming.
Include the True Value of Nature when Rebuilding Economies After Coronavirus
Include the True Value of Nature when Rebuilding Economies After Coronavirus
The pandemic is devastating economies. As countries look to revive growth, recovery must go with - not against - the grain of nature.
Facebook Will Pay $52 Million in Settlement with Moderators Who Developed PTSD on the Job
Facebook Will Pay $52 Million in Settlement with Moderators Who Developed PTSD on the Job
Current and former moderators will all be paid a minimum of $1,000. Selena Scola filed the case in California.
Eat Rat, Make New Body: Easy Stuff for Pythons
The extreme metabolism of some snakes could provide leads on how to regenerate human tissue.
Good Science Is Good Science
For the sake of both science and action in the COVID-19 pandemic, we need collaboration among specialists, not sects.
Doctors Treat Parkinson's with a Novel Brain Cell Transplant
In a secret experiment, researchers replaced the dysfunctional brain cells of a Parkinson's patient with the progeny of an extraordinary type of stem cell.
How Academic Research Helps In The Fight Against The Coronavirus | Tapscape
Academic research is fundamental to learn more about the nature of the coronavirus.
As States Rush to Reopen, Scientists Fear a Coronavirus Comeback
Officials are under pressure to restart the economy, but many states are moving too quickly, researchers say. The costs may be measured in lost lives.
Inside the NIH's Controversial Decision to Stop Its Big Remdesivir Study
At the heart of the decision was a process that was - as is often in the case in clinical trials - by turns secretive and bureaucratic.
Fact-checking Judy Mikovits, the Controversial Virologist Attacking Anthony Fauci in a Viral Conspiracy Video
Fact-checking Judy Mikovits, the Controversial Virologist Attacking Anthony Fauci in a Viral Conspiracy Video
In the video Plandemic, the former chronic fatigue syndrome researcher makes countless unsubstantiated claims and accusations.
A Strategic Approach to COVID-19 Vaccine R&D
A public-private partnership and platform for harmonized clinical trials aims to accelerate licensure and distribution.
"Finally, a Virus Got Me": Scientist Who Fought Ebola and HIV Reflects on Facing Death from COVID-19
"Finally, a Virus Got Me": Scientist Who Fought Ebola and HIV Reflects on Facing Death from COVID-19
Virologist Peter Piot, director of the London School of Hygiene & Tropical Medicine, fell ill with COVID-19 in mid-March.
Our Weird Behavior During the Pandemic is Screwing with AI Models
Machine-learning models trained on normal behavior are showing cracks —forcing humans to step in to set them straight.
'Aggressive' COVID-19 Strains: What It Takes to Correct a Flawed Paper
Scottish researchers have taken aim at a study reporting surprising findings on COVID-19 - but what it took to correct the record is all too familiar.
The Science for Public Good Fund
If you are an early career scientist looking for ways to get involved with advocacy, or a faculty member who wants to engage your students in the role of science in democracy, the Science for Public Good Fund is for you.
In Pursuit of Open Science, Open Access is Not Enough
After decades of debate on the feasibility of open access (OA) to scientific publications, we may be nearing a tipping point. A number of recent developments, such as Plan S, suggest that OA upon publication could become the default in the sciences within the next several years. However, there remains a need for practical, sustainable models, for careful analysis of the consequences of business model choices, and for caution in responding to passionate calls for a 'default to open'.
UK Scientists Furious over Attempt to Censor Covid-19 Advice
Government scientific advisers are furious at what they see as an attempt to censor their advice on government proposals during the Covid-19 lockdown by heavily redacting an official report before it was released to the public.
Speeding Up Science During the Pandemic
It is testament to the machinery of science that so much has been learned about covid-19 so rapidly. Since January the number of publications has been doubling every 14 days, reaching 1,363 in the past week alone. They have covered everything from the genetics of the virus that causes the disease to computer models of its spread and the scope for vaccines and treatments. What explains the speed? Much as in other areas of life, covid-19 has burnt away encrusted traditions.
The ERC: Funding Organisation and European Project
A review of some of the main characteristics that have made the ERC into the successful funding organisation that it is
Greek Scientist Found to Have De-frauded European Research Council
OLAF, the EU's anti-fraud agency, this week confirmed an unnamed Greek scientist de-frauded the European Research Council (ERC) of roughly €190,000. "A complex fraud involving a Greek scientist and her network of international researchers has been uncovered by investigators," OLAF said.
'It Will Not Be Easy.' As Labs Begin to Reopen, Enormous Challenges Remain
What Are Your Priorities for Data Sharing?
To deepen understanding of researchers’ priorities with regards to sharing research data, PLOS has launched a new study.
ResearchGate and Wiley Announce Cooperation Agreement
ResearchGate, the largest professional network for researchers, and Wiley, a global leader in research and education, today announced a cooperation agreement to explore ways in which Wiley and ResearchGate can collaborate to better support the needs of researchers through ResearchGate’s collaboration platform.
×